Transcutaneous oxygen tension in patients with calciphylaxis

William A. Wilmer, Olga Voroshilova, Inderpal Singh, Donald F. Middendorf, Fernando G Cosio

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Calciphylaxis is a severe complication of chronic renal failure, confined almost exclusively to patients on dialysis therapy. Histological characteristics of calciphylaxis include small-vessel calcifications of skin, subcutaneous tissue, and visceral organs. These vascular changes promote tissue ischemia that often results in tissue necrosis. In this study, we investigated the extent of skin ischemia in patients with calciphylaxis by means of transcutaneous oxygen tension (TCPO2) measurement, a noninvasive test that accurately assesses skin oxygenation. TCPO2 levels were measured in 21 patients with calciphylaxis and 21 age- and sex-matched patients without evidence of calciphylaxis (controls). TCPO2 levels were measured bilaterally at the ches, anterior abdomen, and upper thigh while patients breathed room air and after a 30-minute exposure to 100% fraction of inspired oxygen (FIO2). Compared with controls, patients with calciphylaxis showed significantly lower TCPO2 levels at each body region. In both controls and patients with calciphylaxis, lower TCPO2 levels correlated with increased weight and use of hemodialysis. No correlation with serum parathyroid hormone (PTH), serum calcium, or serum phosphorus values was present, although 39% of the patients with calciphylaxis had markedly elevated PTH values (sixfold greater than normal; >300 pg/dL). Low TCPO2 levels in patients with calciphylaxis were documented in body regions with and without skin lesions. In patients with calciphylaxis, extremely low TCPO2 values (≤30 mm Hg while patients breathed room air) were present in 62% of the body regions with skin lesions and 26% of the body regions without lesions. Room-air TCPO2 levels ≤30 mm Hg were present in only 0.8% of the body regions of control patients. TCPO2 levels obtained while patients breathed 100% FIO2 remained lower in patients with calciphylaxis than in controls. In conclusion, TCPO2 levels are abnormally low in patients with calciphylaxis, indicating that severe and diffuse skin ischemia exists, even at areas free of skin lesions. Low TCPO2 values did not substantially increase with 100% FIO2 in many patients with calciphylaxis, suggesting a fixed insufficiency of the skin vessels. This study shows that TCPO2 measurements may allow rapid and noninvasive screening for skin ischemia before the development of skin lesions in patients with calciphylaxis.

Original languageEnglish (US)
Pages (from-to)797-806
Number of pages10
JournalAmerican Journal of Kidney Diseases
Volume37
Issue number4
StatePublished - 2001
Externally publishedYes

Fingerprint

Calciphylaxis
Oxygen
Body Regions
Skin
Ischemia
Patients' Rooms
Air
Parathyroid Hormone
Serum

Keywords

  • Calciphylaxis
  • End-stage renal disease (ESRD)
  • Hemodialysis (HD)
  • Peritoneal dialysis (PD)
  • Transcutaneous oxygen measurement

ASJC Scopus subject areas

  • Nephrology

Cite this

Wilmer, W. A., Voroshilova, O., Singh, I., Middendorf, D. F., & Cosio, F. G. (2001). Transcutaneous oxygen tension in patients with calciphylaxis. American Journal of Kidney Diseases, 37(4), 797-806.

Transcutaneous oxygen tension in patients with calciphylaxis. / Wilmer, William A.; Voroshilova, Olga; Singh, Inderpal; Middendorf, Donald F.; Cosio, Fernando G.

In: American Journal of Kidney Diseases, Vol. 37, No. 4, 2001, p. 797-806.

Research output: Contribution to journalArticle

Wilmer, WA, Voroshilova, O, Singh, I, Middendorf, DF & Cosio, FG 2001, 'Transcutaneous oxygen tension in patients with calciphylaxis', American Journal of Kidney Diseases, vol. 37, no. 4, pp. 797-806.
Wilmer WA, Voroshilova O, Singh I, Middendorf DF, Cosio FG. Transcutaneous oxygen tension in patients with calciphylaxis. American Journal of Kidney Diseases. 2001;37(4):797-806.
Wilmer, William A. ; Voroshilova, Olga ; Singh, Inderpal ; Middendorf, Donald F. ; Cosio, Fernando G. / Transcutaneous oxygen tension in patients with calciphylaxis. In: American Journal of Kidney Diseases. 2001 ; Vol. 37, No. 4. pp. 797-806.
@article{30d14363f41f42dda967844ead502521,
title = "Transcutaneous oxygen tension in patients with calciphylaxis",
abstract = "Calciphylaxis is a severe complication of chronic renal failure, confined almost exclusively to patients on dialysis therapy. Histological characteristics of calciphylaxis include small-vessel calcifications of skin, subcutaneous tissue, and visceral organs. These vascular changes promote tissue ischemia that often results in tissue necrosis. In this study, we investigated the extent of skin ischemia in patients with calciphylaxis by means of transcutaneous oxygen tension (TCPO2) measurement, a noninvasive test that accurately assesses skin oxygenation. TCPO2 levels were measured in 21 patients with calciphylaxis and 21 age- and sex-matched patients without evidence of calciphylaxis (controls). TCPO2 levels were measured bilaterally at the ches, anterior abdomen, and upper thigh while patients breathed room air and after a 30-minute exposure to 100{\%} fraction of inspired oxygen (FIO2). Compared with controls, patients with calciphylaxis showed significantly lower TCPO2 levels at each body region. In both controls and patients with calciphylaxis, lower TCPO2 levels correlated with increased weight and use of hemodialysis. No correlation with serum parathyroid hormone (PTH), serum calcium, or serum phosphorus values was present, although 39{\%} of the patients with calciphylaxis had markedly elevated PTH values (sixfold greater than normal; >300 pg/dL). Low TCPO2 levels in patients with calciphylaxis were documented in body regions with and without skin lesions. In patients with calciphylaxis, extremely low TCPO2 values (≤30 mm Hg while patients breathed room air) were present in 62{\%} of the body regions with skin lesions and 26{\%} of the body regions without lesions. Room-air TCPO2 levels ≤30 mm Hg were present in only 0.8{\%} of the body regions of control patients. TCPO2 levels obtained while patients breathed 100{\%} FIO2 remained lower in patients with calciphylaxis than in controls. In conclusion, TCPO2 levels are abnormally low in patients with calciphylaxis, indicating that severe and diffuse skin ischemia exists, even at areas free of skin lesions. Low TCPO2 values did not substantially increase with 100{\%} FIO2 in many patients with calciphylaxis, suggesting a fixed insufficiency of the skin vessels. This study shows that TCPO2 measurements may allow rapid and noninvasive screening for skin ischemia before the development of skin lesions in patients with calciphylaxis.",
keywords = "Calciphylaxis, End-stage renal disease (ESRD), Hemodialysis (HD), Peritoneal dialysis (PD), Transcutaneous oxygen measurement",
author = "Wilmer, {William A.} and Olga Voroshilova and Inderpal Singh and Middendorf, {Donald F.} and Cosio, {Fernando G}",
year = "2001",
language = "English (US)",
volume = "37",
pages = "797--806",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Transcutaneous oxygen tension in patients with calciphylaxis

AU - Wilmer, William A.

AU - Voroshilova, Olga

AU - Singh, Inderpal

AU - Middendorf, Donald F.

AU - Cosio, Fernando G

PY - 2001

Y1 - 2001

N2 - Calciphylaxis is a severe complication of chronic renal failure, confined almost exclusively to patients on dialysis therapy. Histological characteristics of calciphylaxis include small-vessel calcifications of skin, subcutaneous tissue, and visceral organs. These vascular changes promote tissue ischemia that often results in tissue necrosis. In this study, we investigated the extent of skin ischemia in patients with calciphylaxis by means of transcutaneous oxygen tension (TCPO2) measurement, a noninvasive test that accurately assesses skin oxygenation. TCPO2 levels were measured in 21 patients with calciphylaxis and 21 age- and sex-matched patients without evidence of calciphylaxis (controls). TCPO2 levels were measured bilaterally at the ches, anterior abdomen, and upper thigh while patients breathed room air and after a 30-minute exposure to 100% fraction of inspired oxygen (FIO2). Compared with controls, patients with calciphylaxis showed significantly lower TCPO2 levels at each body region. In both controls and patients with calciphylaxis, lower TCPO2 levels correlated with increased weight and use of hemodialysis. No correlation with serum parathyroid hormone (PTH), serum calcium, or serum phosphorus values was present, although 39% of the patients with calciphylaxis had markedly elevated PTH values (sixfold greater than normal; >300 pg/dL). Low TCPO2 levels in patients with calciphylaxis were documented in body regions with and without skin lesions. In patients with calciphylaxis, extremely low TCPO2 values (≤30 mm Hg while patients breathed room air) were present in 62% of the body regions with skin lesions and 26% of the body regions without lesions. Room-air TCPO2 levels ≤30 mm Hg were present in only 0.8% of the body regions of control patients. TCPO2 levels obtained while patients breathed 100% FIO2 remained lower in patients with calciphylaxis than in controls. In conclusion, TCPO2 levels are abnormally low in patients with calciphylaxis, indicating that severe and diffuse skin ischemia exists, even at areas free of skin lesions. Low TCPO2 values did not substantially increase with 100% FIO2 in many patients with calciphylaxis, suggesting a fixed insufficiency of the skin vessels. This study shows that TCPO2 measurements may allow rapid and noninvasive screening for skin ischemia before the development of skin lesions in patients with calciphylaxis.

AB - Calciphylaxis is a severe complication of chronic renal failure, confined almost exclusively to patients on dialysis therapy. Histological characteristics of calciphylaxis include small-vessel calcifications of skin, subcutaneous tissue, and visceral organs. These vascular changes promote tissue ischemia that often results in tissue necrosis. In this study, we investigated the extent of skin ischemia in patients with calciphylaxis by means of transcutaneous oxygen tension (TCPO2) measurement, a noninvasive test that accurately assesses skin oxygenation. TCPO2 levels were measured in 21 patients with calciphylaxis and 21 age- and sex-matched patients without evidence of calciphylaxis (controls). TCPO2 levels were measured bilaterally at the ches, anterior abdomen, and upper thigh while patients breathed room air and after a 30-minute exposure to 100% fraction of inspired oxygen (FIO2). Compared with controls, patients with calciphylaxis showed significantly lower TCPO2 levels at each body region. In both controls and patients with calciphylaxis, lower TCPO2 levels correlated with increased weight and use of hemodialysis. No correlation with serum parathyroid hormone (PTH), serum calcium, or serum phosphorus values was present, although 39% of the patients with calciphylaxis had markedly elevated PTH values (sixfold greater than normal; >300 pg/dL). Low TCPO2 levels in patients with calciphylaxis were documented in body regions with and without skin lesions. In patients with calciphylaxis, extremely low TCPO2 values (≤30 mm Hg while patients breathed room air) were present in 62% of the body regions with skin lesions and 26% of the body regions without lesions. Room-air TCPO2 levels ≤30 mm Hg were present in only 0.8% of the body regions of control patients. TCPO2 levels obtained while patients breathed 100% FIO2 remained lower in patients with calciphylaxis than in controls. In conclusion, TCPO2 levels are abnormally low in patients with calciphylaxis, indicating that severe and diffuse skin ischemia exists, even at areas free of skin lesions. Low TCPO2 values did not substantially increase with 100% FIO2 in many patients with calciphylaxis, suggesting a fixed insufficiency of the skin vessels. This study shows that TCPO2 measurements may allow rapid and noninvasive screening for skin ischemia before the development of skin lesions in patients with calciphylaxis.

KW - Calciphylaxis

KW - End-stage renal disease (ESRD)

KW - Hemodialysis (HD)

KW - Peritoneal dialysis (PD)

KW - Transcutaneous oxygen measurement

UR - http://www.scopus.com/inward/record.url?scp=0035057568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035057568&partnerID=8YFLogxK

M3 - Article

C2 - 11273880

AN - SCOPUS:0035057568

VL - 37

SP - 797

EP - 806

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 4

ER -